Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA Funding line '2017 ( U.S. NIH Grant/Contract )' was added to the study details, and the page revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4. This change reflects a deployment update to the page rather than modification to study data.SummaryDifference0.0%

- Check43 days agoChange DetectedThe Ukraine site entry was updated from Zaporizhzhia to Zaporizhzhya in the locations list, reflecting a transliteration/name update for the city.SummaryDifference0.0%

- Check50 days agoChange DetectedThe footer revision changed from Revision: v3.6.3 to Revision: v3.6.4. This appears to be a general site update with no change to the study details or user actions.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/history.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study documentation.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.